New York State Common Retirement Fund »

Entrada Therapeutics shares owned by New York State Common Retirement Fund

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by New York State Common Retirement Fund from 13F filings

Historical chart of New York State Common Retirement Fund investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by New York State Common Retirement Fund consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by New York State Common Retirement Fund

Quarter filed Position value Share count Share price at filing
2023-12-31 $134k 8.9k 15.10
2023-09-30 $141k 8.9k 15.80
2023-06-30 $132k 8.7k 15.17
2022-06-30 $999 109 9.17
2022-03-31 $46k 4.9k 9.43

More positions owned by New York State Common Retirement Fund

Microsoft Corporation Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Nvidia Corporation Common Stock (NVDA)
Alphabet Inc - Class A Common Stock (GOOGL)
Meta Platforms Common Stock (META)
Alphabet Inc - Class C Common Stock (GOOG)
Tesla Common Stock (TSLA)
Berkshire Hathaway Inc-cl Common Stock (BRK.B)
Unitedhealth Group Common Stock (UNH)
Eli Lilly & Company Common Stock (LLY)
Jp Morgan Chase & Company Common Stock (JPM)
Broadcom Common Stock (AVGO)
Visa Inc - Class A Common Stock (V)
Mastercard Inc Class A Common Stock (MA)

View all positions for New York State Common Retirement Fund

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
T. Rowe Price Associates
Redmile Group
Vanguard Group
Wellington Management Company
72 Investment Holdings
Charles Schwab Investment Management
TD Asset Management
Bank of New York Mellon
Moore Capital Management
Barclays
Corton Capital
Rhumbline Advisers
Bank of America Corporation

View all funds holding Entrada Therapeutics